A Pensacola, Florida jury yesterday awarded $7 million to a Pensacola man who said that the manufacturer of Accutane failed to warn him that the use of the controversial acne drug could cause a gastrointestinal disease. The Pensacola jury deliberated for two days before finding that Swiss drug-maker Hoffman-La Roche failed to warn that use of Accutane could potentially lead to a condition known as inflammatory bowel disease.
Adam Mason, 31, had his colon removed after he developed the disease. The surgery, he said, made it impossible for him to return to work as a welder.
In May, a New Jersey jury awarded $2.6 million to 36-year-old Andy McCarrell of Alabama, who filed a lawsuit citing claims similar to Mason’s.
To read the complete article see the October 12, 2007 edition of The Pensacola News Journal.
For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.